Arcadia Biosciences Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6,478.00
6,982.00
5,414.00
3,188.00
4,026.00
1,464
Cost of Goods Sold (COGS) incl. D&A
673.00
1,997.00
892.00
895.00
283.00
661
Gross Income
5,805.00
4,985.00
4,522.00
2,293.00
3,743.00
803
SG&A Expense
16,371.00
20,138.00
20,085.00
20,497.00
18,058.00
17,673
EBIT
10,566.00
15,153.00
15,563.00
18,204.00
14,315.00
16,870
Unusual Expense
-
-
239.00
416.00
900.00
3,006
Non Operating Income/Expense
5.00
597.00
530.00
340.00
281.00
394
Interest Expense
626.00
1,394.00
2,658.00
1,319.00
747.00
-
Pretax Income
11,187.00
17,144.00
17,930.00
19,599.00
15,681.00
13,470
Income Tax
167.00
263.00
26.00
25.00
26.00
10
Equity in Affiliates
1,841.00
932.00
-
-
-
-
Consolidated Net Income
13,195.00
18,339.00
17,956.00
19,624.00
15,707.00
13,480
Net Income
13,195.00
18,339.00
17,956.00
19,624.00
15,707.00
13,480
Net Income After Extraordinaries
13,195.00
18,339.00
17,956.00
19,624.00
15,707.00
13,480
Net Income Available to Common
13,195.00
22,077.00
20,727.00
19,624.00
15,707.00
13,480
EPS (Basic)
5.94
53.60
14.60
8.80
7.28
3.58
Basic Shares Outstanding
2,220.30
412.30
1,428.00
2,218.30
2,156.20
3,766.40
EPS (Diluted)
5.94
53.55
14.52
8.85
7.28
3.58
Diluted Shares Outstanding
2,220.30
412.30
1,428.00
2,218.30
2,156.20
3,766.40
EBITDA
10,175.00
14,795.00
15,269.00
17,900.00
14,036.00
16,716
Preferred Dividends
-
3,738.00
2,771.00
-
-
-
About Arcadia Biosciences
View Profile
